SYROS PHARMACEUTICALS INC

Ticker: SYRS CUSIP: 87184Q206 Class: COM NEW

Bain Capital Life Sciences Investors, LLC's Holding History (CIK: 0001703031)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 2,750,151 Value ($000) $632 Avg Close $1.20 Range $0.18 - $3.40
Q3 2024
Shares 2,750,151 Value ($000) $5,913 Avg Close $3.59 Range $1.43 - $6.93
Q2 2024
Shares 2,749,808 Value ($000) $14,189 Avg Close $5.25 Range $4.40 - $6.12
Q1 2024
Shares 2,749,808 Value ($000) $14,711 Avg Close $6.91 Range $5.15 - $8.17
Q4 2023
Shares 2,749,808 Value ($000) $21,421 Avg Close $3.43 Range $2.09 - $8.05
Q3 2023
Shares 2,124,694 Value ($000) $8,393 Avg Close $3.74 Range $2.87 - $4.20
Q2 2023
Shares 2,124,694 Value ($000) $6,693 Avg Close $3.21 Range $2.42 - $4.10
Q1 2023
Shares 2,124,694 Value ($000) $6 Avg Close $3.88 Range $2.58 - $5.67
Q4 2022
Shares 2,124,694 Value ($000) $8 Avg Close $4.34 Range $3.02 - $6.95
Q3 2022
Shares 1,082,404 Value ($000) $6,971 Avg Close $8.12 Range $5.25 - $11.00